Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Clinical trial NCT00321100 · TERMINATED

Trial details

NCT number: NCT00321100
Sponsor: Fox Chase Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2006-04-12
Primary completion: 2009-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.